A EUFOREA comment on a lost comorbidity of asthma
Status PubMed-not-MEDLINE Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu dopisy
PubMed
37391838
PubMed Central
PMC10314597
DOI
10.1186/s13223-023-00816-0
PII: 10.1186/s13223-023-00816-0
Knihovny.cz E-zdroje
- Klíčová slova
- Allergic rhinitis, Asthma, Chronic rhinosinusitis with nasal polyps, Chronic rhinosinusitis without nasal polyps, Comorbidities,
- Publikační typ
- dopisy MeSH
"Epidemiology of comorbidities and their association with asthma control" (Tomisa, G., Horváth, A., Sánta, B. et al. Epidemiology of comorbidities and their association with asthma control. Allergy Asthma Clin Immunol 17, 95 (2021). https://doi.org/10.1186/s13223-021-00598-3 ) is an interesting paper reflecting data collection from more than 12,000 asthmatic patients in Hungary regarding their condition and associated comorbidities. We found it valuable that the paper provides an overview of asthma comorbidities not usually considered in similar reports. Nevertheless, we believe that chronic rhinosinusitis (CRS) with or without nasal polyps (CRSwNP or CRSsNP) should have been listed due to its high incidence and prevalence, its association with asthma which is also endorsed in both GINA and EPOS, as well as in several peer-reviewed scientific papers, and to reflect the role of this comorbidity in poor control and a most severe presentation of asthma for the patient. Consequently, several targeted therapies (especially monoclonal antibodies) used for several years in severe forms of asthma are now indicated also for the effective treatment of nasal polyps.
Department of Allergy and Rhinology Royal National ENT Hospital London UK
Department of Otorhinolaryngology Amsterdam University Medical Centres Amsterdam The Netherlands
Division of Immunity and Infection University College London UK
Zobrazit více v PubMed
Tomisa G, Horváth A, Sánta B, et al. Epidemiology of comorbidities and their association with asthma control. Allergy Asthma Clin Immunol. 2021;17:95. doi: 10.1186/s13223-021-00598-3. PubMed DOI PMC
Sedaghat AR, Kuan EC, Scadding GK. Epidemiology of Chronic Rhinosinusitis: prevalence and risk factors. J Allergy Clin Immunol Pract. 2022;10(6):1395–403. doi: 10.1016/j.jaip.2022.01.016. PubMed DOI
Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy. 2012;67:91–8. doi: 10.1111/j.1398-9995.2011.02709.x. PubMed DOI
Fokkens WJ, Lund VJ, Hopkins C et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020 Apr 1;58(2):82–111. 10.4193/Rhin20.601. PMID: 32226949. PubMed
De Prins L, Raap U, Mueller T, Schmid-Grendelmeier P, Haase CH, Backer V, Fokkens W, Benoist LB, Prokopakis E, Hopkins C, Claeys N, Teeling T, Cypers L, Cools L, Bjermer LH, Diamant Z, Wahn U, Scadding G, Bachert C, Patel SR, Van Staeyen E, Hellings P. White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREA. Front Allergy. 2022 Jun 2;3:889221. 10.3389/falgy.2022.889221. Erratum in: Front Allergy. 2022 Sep 09;3:1001078. PMID: 35769567; PMCID: PMC9234878. PubMed PMC
Claeys N, Teeling MT, Legrand P, Poppe M, Verschueren P, De Prins L, Cools L, Cypers L, Fokkens WJ, Hopkins C, Hellings PW. Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA. Front Allergy. 2021 Oct 29;2:761388. 10.3389/falgy.2021.761388. Erratum in: Front Allergy. 2021 Oct 29;2:789425. PMID: 35386961; PMCID: PMC8974789. PubMed PMC
Håkansson K, Thomsen SF, Konge L, Mortensen J, Backer V, von Buchwald C. A comparative and descriptive study of asthma in chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2014 Sep-Oct;28(5):383-7. 10.2500/ajra.2014.28.4076. PMID: 25198023. PubMed
Håkansson K, Bachert C, Konge L, Thomsen SF, Pedersen AE, Poulsen SS, Martin-Bertelsen T, Winther O, Backer V, von Buchwald C. Airway Inflammation in Chronic Rhinosinusitis with Nasal Polyps and Asthma: The United Airways Concept Further Supported. PLoS One. 2015 Jul 1;10(7):e0127228. 10.1371/journal.pone.0127228. PMID: 26132710; PMCID: PMC4489400. PubMed PMC
Stjärne P, Odebäck P, Ställberg B, Lundberg J, Olsson P. High costs and burden of illness in acute rhinosinusitis: real-life treatment patterns and outcomes in swedish primary care. Prim Care Resp J. 2012;21:174–9. doi: 10.4104/pcrj.2012.00011. PubMed DOI PMC
Remenschneider AK, Scangas G, Meier JC, et al. EQ-5D-derived health utility values in patients undergoing surgery for chronic rhinosinusitis. Laryngoscope. 2015;125:1056–61. doi: 10.1002/lary.25054. PubMed DOI
Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995;113:104–9. doi: 10.1016/S0194-59989570152-4. PubMed DOI
Teul I, Zbislawski W, Baran S, Czerwinski F, Lorkowski J. Quality of life of patients with diseases of sinuses. J Physiol Pharmacol. 2007;58(Suppl 5):691–7. PubMed
Hellings PW, SWOT Analysis of Chronic Rhinosinusitis Care Anno. 2022. The Journal of Allergy and Clinical Immunology: In Practice. 2022;10(6):1468-71. PubMed
Tomassen P, Vandeplas G, Van Zele T et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137:1449-56.e4. PubMed
Yoo KH, Ahn HR, Park JK, et al. Burden of Respiratory Disease in Korea: an observational study on allergic Rhinitis, Asthma, COPD, and Rhinosinusitis. Allergy Asthma Immunol Res. 2016;8:527–34. doi: 10.4168/aair.2016.8.6.527. PubMed DOI PMC
Yoo KH, Ahn HR, Park JK, et al. Burden of Respiratory Disease in Korea: an observational study on allergic Rhinitis, Asthma, COPD, and Rhinosinusitis. Allergy Asthma Immunol Res. 2016;8:527–34. doi: 10.4168/aair.2016.8.6.527. PubMed DOI PMC
Hellings PW, Prokopakis EP. Global airway disease beyond allergy. Curr Allergy Asthma Rep. 2010;10:143–9. doi: 10.1007/s11882-010-0107-1. PubMed DOI
Giovannini-Chami L, Paquet A, Sanfiorenzo C, Pons N, Cazareth J, Magnone V, Lebrigand K, Chevalier B, Vallauri A, Julia V, Marquette CH, Marcet B, Leroy S, Barbry P. The “one airway, one disease” concept in light of Th2 inflammation. Eur Respir J. 2018 Oct 25;52(4):1800437. 10.1183/13993003.00437-2018. PMID: 30190271. PubMed
Fokkens W, Reitsma S. Unified Airway Disease: a contemporary review and introduction. Otolaryngol Clin North Am. 2023;56(1):1–10. doi: 10.1016/j.otc.2022.09.001. PubMed DOI
Philpott CM, Erskine S, Hopkins C, et al. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study. Respir Res. 2018;19:129. doi: 10.1186/s12931-018-0823-y. PubMed DOI PMC
Ostovar A, Fokkens WJ, Vahdat K, Raeisi A, Mallahzadeh A, Farrokhi S. Epidemiology of chronic rhinosinusitis in Bushehr, southwestern region of Iran: a GA2LEN study. Rhinology. 2019;57:43–8. doi: 10.4193/Rhin18.061. PubMed DOI
Massoth L, Anderson C, McKinney KA. Asthma and chronic Rhinosinusitis: diagnosis and Medical Management. Med Sci (Basel) 2019;7. PubMed PMC
Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017 Oct;140(4):950–8. 10.1016/j.jaci.2017.03.050. Epub 2017 Jun 8. PMID: 28602936. PubMed
De Greve G, Hellings PW, Fokkens WJ, Pugin B, Steelant B, Seys SF. Endotype-driven treatment in chronic upper airway diseases. Clin Transl Allergy. 2017;7:22. doi: 10.1186/s13601-017-0157-8. PubMed DOI PMC
Hens G, Vanaudenaerde BM, Bullens DM, et al. Sinonasal pathology in nonallergic asthma and COPD: ‘united airway disease’ beyond the scope of allergy. Allergy. 2008;63:261–7. doi: 10.1111/j.1398-9995.2007.01545.x. PubMed DOI
Braunstahl GJ, Fokkens WJ, Overbeek SE, KleinJan A, Hoogsteden HC, Prins JB. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways. Clin Exp Allergy. 2003 May;33(5):579 – 87. 10.1046/j.1365-2222.2003.01652.x. PMID: 12752585. PubMed
Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394:1638–50. doi: 10.1016/S0140-6736(19)31881-1. PubMed DOI
Weinstein SF, Katial RK, Bardin P et al. Effects of Reslizumab on Asthma Outcomes in a subgroup of eosinophilic asthma patients with self-reported chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 2019;7:589 – 96.e3. PubMed
Tiotiu A, Oster JP, Roux P, et al. Omalizumab’s effectiveness in severe allergic asthma and nasal polyps: a real-life study. J Investig Allergol Clin Immunol. 2019 doi: 10.18176/jiaci.0391:0. PubMed DOI
Ostovar A, Fokkens WJ, Vahdat K, Raeisi A, Mallahzadeh A, Farrokhi S. Epidemiology of chronic rhinosinusitis in Bushehr, southwestern region of Iran: a GA2LEN study. Rhinology. 2019;57:43–8. doi: 10.4193/Rhin18.061. PubMed DOI
Striz I, Golebski K, Strizova Z, Loukides L, Bakakos P, Hanania NA, Jesenak M, Diamant Z. New Insights into the pathophysiology and therapeutic targets of Asthma and Comorbid Chronic Rhinosinusitis with or without nasal polyposis. Clin Sci. 2023 doi: 10.1042/cs20190281. PubMed DOI PMC
Bel E, ten Brinke A. A rational approach to the management of severe refractory asthma. Treat Respir Med. 2005;4(6):365 – 79. 10.2165/00151829-200504060-00002. PMID: 16336023. PubMed
Ten Brinke A, Grootendorst DC, Schmidt JT, De Bruïne FT, van Buchem MA, Sterk PJ, Rabe KF, Bel EH. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol. 2002 Apr;109(4):621-6. 10.1067/mai.2002.122458. PMID: 11941310. PubMed
Hamilos DL. Chronic rhinosinusitis: epidemiology and medical management. J Allergy Clin Immunol. 2011 Oct;128(4):693–707; quiz 708-9. 10.1016/j.jaci.2011.08.004. Epub 2011 Sep 3. PMID: 21890184. PubMed
Aarab R, Vijverberg SJH, Prins M, et al. Prevalence of and factors associated with adult-onset asthma in different ethnic groups: the HELIUS study. Respir Med. 2019;150:113–9. doi: 10.1016/j.rmed.2019.02.018. PubMed DOI
Grossman NL, Ortega VE, King TS, et al. Exacerbation-prone asthma in the context of race and ancestry in Asthma Clinical Research Network trials. J Allergy Clin Immunol. 2019;144:1524–33. doi: 10.1016/j.jaci.2019.08.033. PubMed DOI PMC
Chen YT, Chien CY, Tai SY, Huang CM, Lee CT. Asthma associated with chronic rhinosinusitis: a population-based study. Int Forum Allergy Rhinol. 2016;6:1284–93. doi: 10.1002/alr.21813. PubMed DOI
Vashishta R, Soler ZM, Nguyen SA, Schlosser RJ. A systematic review and meta-analysis of asthma outcomes following endoscopic sinus surgery for chronic rhinosinusitis. Int Forum Allergy Rhinology. 2013;3:788–94. doi: 10.1002/alr.21182. PubMed DOI
Vashishta R, Soler ZM, Nguyen SA, Schlosser RJ. A systematic review and meta-analysis of asthma outcomes following endoscopic sinus surgery for chronic rhinosinusitis. Int Forum Allergy Rhinology. 2013;3:788–94. doi: 10.1002/alr.21182. PubMed DOI